Epidemiological, clinical, and molecular study of a cohort of Italian Parkinson disease patients: Association with glutathione-s-transferase and DNA repair gene polymorphisms

Cellular and Molecular Neurobiology

Volumn 33, Issue 5, 2013, Pages 673-680

  Cornetta, Tommaso ^a,e   Patrono, Clarice ^b   Terrenato, Irene ^c   De Nigris, Francesca ^d   Bentivoglio, Anna Rita ^d   Testa, Antonella ^b   Palma, Valentina ^b   Poggioli, Tommaso ^b   Padua, Luca ^e   Cozzi, Renata ^a  

^a ROMA TRE UNIVERSITY   (Italy)

^b ENEA C R CASACCIA   (Italy)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

^e IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

Gene polymorphisms; GSTs; OGG1; Parkinson disease; SNPs; XRCC1

Indexed keywords

BENSERAZIDE PLUS LEVODOPA; CARBIDOPA PLUS LEVODOPA; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; LEVODOPA; SELEGILINE; XRCC1 PROTEIN; DNA BINDING PROTEIN; DNA GLYCOSYLTRANSFERASE; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE S-TRANSFERASE T1; GSTP1 PROTEIN, HUMAN; OXOGUANINE GLYCOSYLASE 1, HUMAN; X-RAY REPAIR CROSS COMPLEMENTING PROTEIN 1;

ADULT; AEROBIC METABOLISM; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE DURATION; DNA POLYMORPHISM; DNA REPAIR; FEMALE; GENE; GENE ACTIVITY; GENE FUNCTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; GSTM1 GENE; GSTP1 GENE; GSTT1 GENE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; OGG1 GENE; PARKINSON DISEASE; PRIORITY JOURNAL; SEX DIFFERENCE; XRCC1 GENE; CASE CONTROL STUDY; DEMOGRAPHY; ENZYMOLOGY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; RISK; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DEMOGRAPHY; DNA GLYCOSYLASES; DNA REPAIR; DNA-BINDING PROTEINS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; ITALY; MALE; MIDDLE AGED; ODDS RATIO; PARKINSON DISEASE; POLYMORPHISM, GENETIC;

EID: 84878727138     PISSN: 02724340     EISSN: 15736830     Source Type: Journal    
DOI: 10.1007/s10571-013-9933-8     Document Type: Article

References (39)

1. Alves G, Forsaa EB, Pedersen KF, Dreetz Gjerstad M, Larsen JP (2008) Epidemiology of Parkinson's disease. J Neurol 255:18-32
2. Baez S, Segura-Aguilar J, Widersten M, Johansson AS, Mannervik B (1997) Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes. Biochem J 324:25-28
3. Chartier-Harlin MC, Dachsel JC, Vilariño-Güell C, Lincoln SJ, Leprêtre F et al (2011) Translation initiator EIF4G1 mutations in familial Parkinson disease. Am J Hum Genet 89:398-406
4. Cooke MS, Evans MD, Dizdaroglu M, Lunec J (2003) Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 17:1195-1214
5. Coppedè F, Ceravoloa R, Migheli F, Fanucchi F, Frosini D, Siciliano G, Bonuccelli U, Migliore L (2010) The hOGG1 Ser326Cys polymorphism is not associated with sporadic Parkinson's disease. Neurosci Lett 473:248-251
6. Cornetta T, Festa F, Testa A, Cozzi R (2006) DNA damage repair and genetic polymorphisms: assessment of individual sensitivity and repair capacity. Int J Radiat Oncol Biol Phys 66:537-545
7. Deng Y, Newman B, Dunne MP, Silburn PA, Mellick GD (2004) Case-only study of interactions between genetic polymorphisms of GSTM1, P1, T1 and Z1 and smoking in Parkinson's disease. Neurosci Lett 366:326-331
8. Dogru-Abassoglu S, Aykac-Toker G, Hanagasi HA, Gurvit H, Emre M, Uysal M (2007) The Arg194Trp polymorphism in DNA repair gene XRCC1 and the risk for sporadic late-onset Alzheimer's disease. Neurol Sci 28:31-34
9. Evangelou E, Maraganore DM, Ioannidis JPA (2007) Meta-analysis in genome-wide association datasets: strategies and application in Parkinson disease. PLoS ONE 2:c196
10. Fukae J, Takanashi M, Kubo S, Nishioka K, Nakabeppu Y, Mori H et al (2005) Expression of 8-oxoguanine DNA glycosylase (OGG1)in Parkinson's disease and related neurodegenerative disorders. Acta Neuropathol (Berl) 109:256-262
11. Gelb D, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56:33-39
12. Hardy J, Lewis P, Revesz T, Lees A, Paisan-Ruiz C (2009) The genetics of Parkinson's syndromes: a critical review. Curr Opin Genet Dev 19:254-265
13. Hoehn M, Yahr M (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427-442
14. Houlden H, Singleton AB (2012) The genetics and neuropathology of Parkinson's disease. Acta Neuropathol 124:325-338
15. Jenner P (2003) Oxidative stress in Parkinson's disease. Ann Neurol 53(Suppl 3):S26-36
16. Kelada SN, Stapleton PL, Farin FM, Bammler TK, Eaton DL, Smith-Weller T et al (2003) Glutathione-S-transferase M1, T1, and P1 polymorphisms and Parkinson's disease. Neurosci Lett 337:5-8
17. Kiyohara C, Miyake Y, Koyanagi M et al (2010) GST polymorphisms, interaction with smoking and pesticide use, and risk for Parkinson's disease in a Japanese population. Parkinsonism Relat Disord 16:447-452
18. Lill CM et al (2012) Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: the PDGene database. PLoS Genet 8:1-10
19. Martin LJ (2008) DNA damage and repair: relevance to mechanisms of neurodegeneration. J Neuropathol Exp Neurol 67:377-387
20. Migliore L, Petrozzi L, Lucetti C, Gambaccini G, Bernardini S, Scarpato R et al (2002) Oxidative damage and cytogenetic analysis in leukocytes of Parkinson's disease patients. Neurology 58:1809-1815
21. Nakabeppu Y, Kajitani K, Sakamoto K, Yamaguchi H, Tsuchimoto D (2006) MTH1 an oxidized purine nucleoside triphosphatase, prevents the cytotoxicity and neurotoxicity of oxidized purine nucleotides. DNA Repair (Amst.) 5:761-772
22. Nakabeppu Y, Tsuchimoto D, Yamaguchi H, Sakumi K (2007) Oxidative damage in nucleic acids and Parkinson's disease. J Neurosci Res 85:919-934
23. Nishimura M, Kuno S, Kaji R, Yasuno K, Kawakami H (2005) Glutathione-S-transferase-1 and interleukin-1 beta gene polymorphisms in Japanese patients with Parkinson's disease. Mov Disord 20:901-902
24. Olanow CW, Tatton WG (1999) Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci 22:123-144
25. Parildar-Karpuzoglu H, Dogru-Abassoglu S, Hanagasi HA, Karadag BH, Gurvit H, Emre M et al (2008) Single nucleotide polymorphisms in base-excision repair genes hOGG1, APE1 and XRCC1 do not alter risk of Alzheimer's disease. Neurosci Lett 442:287-291
26. Perez-Pastene C, Graumann R, Diaz-Grez F, Miranda M, Venegas P, Godoy OT et al (2007) Association of GSTM1 null polymorphism with Parkinson's disease in a Chilean population with a strong Amerindian genetic component. Nurosci Lett 418:181-185
27. Petrozzi L, Lucetti C, Gambaccini G, Bernardini S, Del Dotto P, Migliore L et al (2001) Cytogenetic analysis oxidative damage in lymphocytes of Parkinson's disease patients. Neurol Sci 22:83-84
28. Satake W, Nakabayashi Y, Mizuta I, Hirota Y, Ito C et al (2009) Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet 41:1303-1307
29. Sherer TB, Betarbet R, Greenamyre JT (2001) Pathogenesis of Parkinson's disease. Curr Opin Investig Drugs 2:657-662
30. Shinmura K, Yokota J (2001) The OGG1 gene encodes a repair enzyme for oxidatively damaged DNA and is involved in human carcinogenesis. Antioxid Redox Signal 3:597-609
31. Simón-Sánchez J, Schulte C, Bras JM, Sharma M, Gibbs JR et al (2009) Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet 41:1308-1312
32. Singh M, Khan AJ, Shah PP, Shukla R, Khanna VK, Parmar D (2008) Polymorphism in environment responsive genes and association with Parkinson disease. Mol Cell Biochem 312:131-138
33. Tan EK (2007) The role of common genetic risk variants in Parkinson disease. Clin Genet 72:387-393
34. Vilariño-Güell C, Wider C, Ross OA, Dachsel JC, Kachergus JM et al (2011) VPS35 mutations in Parkinson disease. Am J Hum Genet 89:162-167
35. Wahner AD, Glatt CE, Bronstein JM, Ritz B (2007) Glutathione-S- transferase mu, omega, pi, and theta class variants and smoking in Parkinson's disease. Neurosci Lett 413:274-278
36. Warner TT, Schapira AH (2003) Genetic and environmental factors in the cause of Parkinson's disease. Ann Neurol 53:S16-S25
37. Wilson DM, McNeill DR (2007) Base excision repair and the central nervous system. Neuroscience 145:1187-1200
38. Zhong S, Wyllie AH, Barnes D, Wolf CR, Spurr NK (1993) Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis 14:1821-1824
39. Zimprich A, Benet-Pagès A, Struhal W, Graf E, Eck SH et al (2011) A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. Am J Hum Genet 89:168-175